Abbvie Inc’s filing revealed that its EVP, CHIEF OPERATIONS OFFICER SALEKI-GERHARDT AZITA unloaded Company’s shares for reported $8.41 million on Aug 12 ’25. In the deal valued at $198.42 per share,42,370 shares were sold. As a result of this transaction, SALEKI-GERHARDT AZITA now holds 177,292 shares worth roughly $36.62 million.
Then, AZITA SALEKI-GERHARDT bought 42,370 shares, generating $8,407,068 in total proceeds.
Before that, Richard A. Gonzalez bought 61,500 shares. Abbvie Inc shares valued at $12,043,268 were divested by the Former Director at a price of $195.83 per share.
A number of analysts have revised their coverage, including Daiwa Securities’s analysts, who increased its forecast for the stock in early August from “a Neutral” to “an Outperform”. Citigroup also remained covering ABBV and has decreased its forecast on May 14, 2025 with a “Neutral” recommendation from previously “Buy” rating. Cantor Fitzgerald started covering the stock on April 22, 2025. It rated ABBV as “an Overweight”.
Price Performance Review of ABBV
On Monday, Abbvie Inc [NYSE:ABBV] saw its stock fall -0.06% to $206.57. Over the last five days, the stock has gained 3.99%. Abbvie Inc shares have risen nearly 7.03% since the year began. Nevertheless, the stocks have risen 16.25% over the past one year. While a 52-week high of $218.66 was reached on 03/10/25, a 52-week low of $163.81 was recorded on 04/09/25.
Levels Of Support And Resistance For ABBV Stock
The 24-hour chart illustrates a support level at 205.57, which if violated will result in even more drops to 204.58. On the upside, there is a resistance level at 207.95. A further resistance level may holdings at 209.34.
How much short interest is there in Abbvie Inc?
A steep rise in short interest was recorded in Abbvie Inc stocks on 2025-07-31, dropping by -0.83 million shares to a total of 15.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 15.95 million shares. There was a decline of -5.46%, which implies that there is a negative sentiment for the stock.
